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Spinal cord injury (SCI) is a trauma with highincidence in central nervous system. At present,there is no universally accepted treatment for
spinal cord injury. Not only are neurons highly vulner-
able to the impairment, but oligodendrocytes also seem
susceptible to those harmful factors. As the conse-
quence of oligodendrogial death, the demyelination of
survived axons and deterioration of neural function fur-
ther develop in the lesion areas. Recently, with better
understanding of the cellular and molecular biology of
oligodendrocytes and demyelination in spinal cord
injury, the role of oligodendrocytes in axonal demyeli-
nation catch more attention. Profyris et al. 1 have de-
monstrated that oligodendroglial death and consequent
demyelination of spared axons played a role in the func-
tional impairment of spinal cord. Therefore, the minimi-
zation of oligodendrocyte death following spinal cord
injury may have a favorable effect on the functional res-
toration of injured spinal cord. Nowadays, cell trans-
plantation is regarded as one of the promising thera-
peutic strategies to facilitate axonal remyeliantion and
functional restoration in spinal cord injury. Thus, reduc-
tion of oligodendroglial loss and facilitation of axonal
remyelination after injury likely improve the recovery of
neural function in spinal cord injury.2,3
Axonal demyelination in spinal cord injury
Myelin sheath is an essential constituent in ner-
vous system. Its unique composition and segmental
distribution support fast saltatory conduction of nerve
impulse along nerve fibers in vertebrae. Furthermore,
both myelin sheath and myelinating cells have other
important biological effects on axons. Sanchez et al.4
have shown that the signals from myelinating cells were
vital to induce axonal growth by triggering accumula-
tion and organization of the local neurofilament network.
Both demyelination of axons and dysfunction of
myelinating cells have adverse effects on the neural
function of spinal cord.
Axonal demyelination is one of the most prominent
pathological changes observed in spinal cord injury. The
demyelination of axons in spinal cord injury initially
takes place at the injury epicenter, then it chronically
progresses in the adjacent white matter fasciculus.
Totoiu et al. 5 have detailedly documented the extent of
axonal demyelination and its functional impairment in
spinal cord injury during a long period of 450 days. The
total number of demyelinated axons peaked one day
after injury, declined within 7-14 days after injury and
then it progressively increased up to 450 days. This
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study clearly demonstrated that there was chronic axo-
nal demyelination following spinal cord injury. And the
authors further proposed that intervention of axonal de-
myelination could have important therapeutic implica-
tion in the treatment for spinal cord injury.
The insulating property of myelin sheath and its
segmental distribution favor rapid conduction velocity.
With demyelination of axons in spinal cord injury, the
“unmasked” potassium channels of axons clamp mem-
brane potential close to resting potential, which further
interferes with normal nerve conduction. Since axonal
demyelination and other pathological changes simulta-
neously exist in the lesion site, it is impossible to ac-
curately evaluate the extent to which axonal demyeli-
nation contributes to functional impairment in spinal cord
injury. However, the recovery of neural function in spi-
nal cord injury could partly benefit from the ameliora-
tion of axonal myelination through prevention of demy-
elination or facilitation of remyelination. Recently, sev-
eral experiments have proved that amelioration of ax-
onal myelination could facilitate the recovery of neural
function in spinal cord injury. Shi et al.6 have revealed
that 4-aminopyridine (a potassium channel blocker)
could improve nerve conduction and consequently fa-
cilitate functional recovery in spinal cord injury.
Furthermore, Utzschneider et al. 7 also demonstrated
that myelinating cells transplanted into the demyeli-
nated spinal cord of neonatal rats with myelin-deficiency
could enhance myelin formation and consequently in-
crease the conduction velocity of the lesioned axons.
The above-mentioned research findings together indi-
cate that normal myelination of axons is necessary to
maintain the normal function of spinal cord.
Mechanisms of axonal demyelination
The myelin-forming cells in central nervous system
exclusively come from oligodendrocytes. It is thought
that demyelination of axons is likely to have close rela-
tionship with the dysfunction of oligodendrocytes in
spinal cord injury. Recently, several experiments have
presented the convincing evidence to support this
concept. Some scientists have reported that spinal cord
injury could result in white matter degeneration and the
death of intrafascicular oligodendrocytes in spinal cord
injury of rats and monkeys.8 Moreover, Beattie et al.9
have also observed oligodendroglial apoptosis within 24
hours after spinal cord injury and this process at least
lasted up to 3 weeks postinjury. Finally, this study also
suggested that the loss of oligodendrocyte after spinal
cord injury could be related with the demyelination of
axons. Furtheremore, Warden et al.10 have found that
cellular apoptosis following spinal cord injury greatly
occured in the areas of Wallerian degeneration within
the tracts, and oligodendrocytes were also considerd
to be responsible for some of those apoptotic cells.
With recent advancement in neuroscience, the
mechanism of oligodendrocyte death in spinal cord in-
jury becomes clearer. Xu et al.11 have revealed that suf-
ficient glutamate accumulated in the lesion area follow-
ing spinal cord injury could kill oligodendrocytes and
damage white matter. This work clearly showed that
the accumulation of excitatory amino acids in spinal
cord injury reached the concentration, which was harmful
to the oligodendrocytes. Moreover, Shuman et al.12
found that apoptosis of oligodendrocytes partly resulted
from insufficiency of trophic factors. They considered
that the loss of oligodendrocytes was associated with
the demyelination of survived axons.
It is known that caspases play a vital role in cellular
apoptosis. Recently, several investigations have also
proved that caspases are activated in contusive injury
of spinal cord. The double-labelled immunohistochem-
istry further reveals that the active caspases are prima-
rily located in neurons and oligodendrocytes. Moreover,
intrathecal delivery of caspase inhibitors can improve
the neural function of treated animals.13,14 Casha et al.15
have further demonstrated that the expression of FAS
and p75 protein is elevated in the apoptotic oligoden-
drocytes in spinal cord injury of rats and the downstream
molecules, caspase-3 and caspase-8, were activated
at the same time. Based on the above research findings,
it is concluded that the demyelination of axons in spi-
nal cord injury has close relationship with dysfunction
of oligodendrocytes and the apoptosis of oligodendro-
cytes is an important pathological change in the axonal
demyeliantion.
Experimental treatment of axonal demyelination
The loss of oligodendrocytes and subsequent de-
myelination of axons in spinal cord injury continue to
be an insidious and challenging problem for neurologi-
cal researchers. Currently, the therapeutic strategies
to improve axonal myelination after spinal cord injury
generally fall into two major aspects: (1) to minimize
demyel ination of  axons;  and (2) to promote
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remyelination of demyelinated axons.
Secondary to spinal cord injury, oligodendrocytes
die by waves of apoptosis. Consequently, it results in
demyelination of spared axons and further impairs neu-
ral function of survived axons. As oligodendrogial death
is associated with axonal demyelination in spinal cord
injury, the reduction of oligodendrocyte loss and pre-
vention of axonal demyelination likely facilitate functional
recovery of injured spinal cord. Lack of neurotrophic sub-
stance in lesion area after spinal cord injury is thought to
contribute to the death of oligodendrocytes. Therefore,
supply of trophic factors into lesion site may save the
dying oligodendrocytes. Koda et al.16 have documented
that continuous intrathecal infusion of neurotrophic fac-
tor immediately after the spinal cord injury of rats could
significantly reduce the number of apoptotic oligoden-
drocytes in the white matter rostral and caudal to the
epicenter. Jiang et al. 17 also demonstrated that the ad-
ministration of guanosine for 7 consecutive days
postinjury could improve axonal remyelination and neural
function of injured cord. Guanosine can stimulate pro-
liferation and differentiation of many types of cells in
vitro. In their experiment, it enhanced functional improve-
ment correlated with the increase in myelination of in-
jured cord. It was also proved that the myelinogenesis
in treatment groups was associated with an increase
of survived oligodendrocytes. The study further indicated
that functional improvement and remyelination after
systemic administration of guanosine were due to the
effect of guanosine on the proliferation of adult progeni-
tor cells and their maturation into myelin-forming cells.18
Leukemia inhibitory factor (LIF), a pleiotropic cytokine,
is proved to support oligodendrocyte survival in spinal
cord injury. Several studies have shown that systemic
delivery of LIF in spinal cord injury can increase oligo-
dendroglial survival and ameliorate axonal myelination.
Furthermore, it was also revealed that the prevention of
oligodendroglial apoptosis by LIF was via the induction
of JAK/STAT and Akt signaling pathways as well as via
potentiating the expression of antiapoptotic molecule,
cIAP2.19
Caspase pathway is involved in the death of oligo-
dendrocytes in spinal cord injury. Dong et al.20 indi-
cated that inhibiting activation of caspases after spinal
cord injury could protect oligodendrocytes from death.
Moreover, Nottingham et al.21 have shown that the
immunosuppressant, FK506, could also inhibit the ac-
tivation of caspase-3 in the treated animals with spinal
cord injury and the number of survived oligodendrocytes
in the lesion site increased as well. The research find-
ings suggested that FK506 could reduce oligodendro-
glial apoptosis and axonal demyelination, thus further
improve the neural function. On the whole, protection of
oligodendroglial cells from secondary injuries is able to
ameliorate axonal myelination and consequently to en-
hance functional recovery of spinal cord injury.
Spinal cord injury can cause necrosis of the spinal
cord, but the long white matter tracts outside the cen-
tral necrotic core are often demyelinated. One experi-
mental strategy to improve functional outcome follow-
ing spinal cord injury is to transplant myelin-forming
cells to remyelinate these axons and improve
conduction. Recently, cell replacement is regarded as
one of the most promising strategies to ameliorate
myelination of axons and restore conductive function in
spinal cord injury. Replenishment with myelinating cells
has become an important method to promote axonal
remyelination in spinal cord injury. The candidate cells
for transplantation are mainly Schwann cells, olfactory
ensheathing cells (OECs), oligodendrocyte precursor
cells, embryonic or neural stem cells, etc.22
Schwann cells play a vital role in the remyelination
of axons after peripheral nervous system injury. Thus,
Schwann cells have been considered as a candidate to
enhance axonal remyelination in spinal cord injury.
However, their integration into spinal cord tissue is mostly
inhibited by astrocytes and the use of Schwann cells
for cell transplantation in spinal cord injury is greatly
limited. Recently, Papastefanaki et al.23 have trans-
planted genetically modified Schwann cells, which ex-
press polysialylated form of neural cell adhesion mol-
ecule on their surface, into the mouse with spinal cord
injury. As a result, the treated animals had a faster and
better functional recovery. Furthermore, this research
also indicated that the improvement of locomotor func-
tion was associated with enhanced axonal remyelination
by modified Schwann cells.
During the past decade, as one of the myelinating
cells, OECs have brought a promising future to facili-
tate extensive remyelination and axonal regeneration.
Transplantation of OECs to improve axonal remyelination
and functional outcome in experimental models of spi-
nal cord injury has been widely studied. 24 In animal
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models of spinal cord injury, the implanted OECs sur-
vive and migrate well in the lesion area, which further
supports the remyelination of axons.25 Sasaki et al.26
transplanted the OECs into a dorsal spinal cord transec-
tion lesion of rat model. These implanted OECs sur-
vived well in the lesion area and longitudinally distrib-
uted along axons and the locomotor function of ani-
mals in the OECs-treated groups was correspondingly
improved. The immunostaining further revealed that the
remyelination of axons was derived from the engrafted
OECs. Furthermore, in a phase I clinical trial, Féron et
al.27 have proved the feasibility and safety of transplan-
tation of autologous OECs to treat human spinal cord
injury. The early results showed that there were no
changes in psychosocial status and no evidences of
deterioration in neurological status of those patients.
Replenishment of lost oligodendrocytes and
remyelination of spared axons are expected to signifi-
cantly improve neural function in spinal cord injury. In
order to explore the potential of oligodendrocytes to
repair spinal cord injury, Bambakidis et al.28 have trans-
planted oligodendrocyte precursor cells to treat the in-
complete contusive spinal cord injury. The results
showed the improvement of behavior and electrophysi-
ological function in the treatment groups were better
than that of control. Furthermore, histological exami-
nation revealed more white matter areas spared in the
transplanted groups and immunohistochemical analy-
sis also showed the survival, proliferation and migration
of the engrafted cells in lesion area. Recently, Keirstead
et al.29 also demonstrated that transplantation of oligo-
dendrocyte progenitor cells in a rat model of spinal cord
injury could enhance axonal remyelination and promote
recovery of locomotor function. The transplanted cells
survived and differentiated into mature oligodendrocytes.
From above-mentioned research findings, it can be con-
cluded that transplantation of oligodendrocytes can
ameliorate axonal myelination and promote the recovery
of neural function in spinal cord injury.
Furthermore, some stem cells are also investigated
as candidates to improve remyelination of axons in
spinal cord injury. Adult brain-derived neural precursor
cells (NPCs) have been transplanted into injured spinal
cord of adult rats.30 The results showed that the NPCs
survived up to 10 weeks, mainly integrated along white
matter tracts and displayed close contact to the host
axons. The motor functional recovery was also improved
in the treated rats. Those grafted cells formed either oligo-
dendrocyte precursor cells or mature oligodendrocytes.
The NPC-derived oligodendrocytes further expressed
myelin basic protein and ensheathed the axons. Dasari
RV et al.31 have transplanted human umbilical cord blood
stem cells (hUCB) to treat spinal cord injury of adult
rats. Those implanted hUCB differentiated into several
neural phenotyes including oligodendrocytes, which
could further form myelin sheaths around axons in the
injured area of spinal cord. The study has further proved
that oligodendrocytes derived from hUCB secrete neu-
rotrophic factors, which play a role in synthesis of my-
elin basic protein and proteolipid of myelin in the in-
jured areas, thereby facil i tate the process of
remyelination and the functional recovery after moderate
spinal cord injury.
Conclusion
Generally speaking, the measures to save oligo-
dendrocytes and prevent demyelination of axons are
expected to cause significant improvement of neural
function in spinal cord injury. After acute phase of injury,
there seems to be a therapeutic window of opportunity
to reduce the loss of oligodendrocytes, minimize de-
myelination of spared axons and consequently benefit
the recovery of neural function. Naturally, spontaneous
remyelination in spinal cord injury is mostly limited.
Therefore, cell replacement has been regarded as a
promising approach to replenish lost oligodendrocytes
and ameliorate axonal myelination in spinal cord injury.
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